Longevity clinic market seen topping $26.1 billion by 2030

The global longevity clinic and precision anti-aging therapy market is projected to nearly double from 2025 to 2030 as aging populations, preventive care demand and AI-enabled health tools accelerate adoption. North America led in 2025, while Asia-Pacific is expected to grow fastest over the forecast period.

Why it matters: - The market is moving from a niche wellness category toward a broader healthspan and preventive-care industry. - Demand is being driven by older populations, rising interest in personalized medicine and growing use of digital health tools. - The forecast suggests a fast-growing opportunity for clinics, diagnostics firms and wellness providers targeting affluent consumers and aging populations.

What happened: - The Business Research Company released its Global Longevity Clinic & Precision Anti-Aging Therapy Global Market Report 2026. - The report estimates the market will rise from $12.38 billion in 2025 to $14.41 billion in 2026. - The report projects the market will reach $26.1 billion by 2030. - The report forecasts a 16.4% CAGR from 2025 to 2026 and a 16.0% CAGR through 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - Longevity clinics and precision anti-aging therapy centers assess biological age and individual health risks using advanced diagnostics, biomarkers and precision medicine. - These clinics use genetic, metabolic and hormonal information to tailor interventions. - The stated goal is to extend healthspan, prevent age-related disease and improve overall wellness. - The market’s historic growth has been supported by rising age-related conditions, stronger demand for preventive healthcare, advances in genetic and biomarker diagnostics, more private healthcare facilities and greater public awareness of healthy aging. - The report says future growth will be supported by preference for personalized precision medicine, wider use of AI-powered health optimization platforms, progress in regenerative medicine and stem cell research, longevity tourism, premium wellness services and wearable-based health monitoring. - The report highlights upcoming trends including AI-enabled personalized treatment plans, predictive aging analytics, regenerative and cellular reprogramming therapies, telehealth-based consultations, remote monitoring, senolytic and anti-aging drugs, and premium clinic demand from high-net-worth individuals. - A U.S. Census Bureau update in April 2026 showed the median age in the U.S. rose from 39.2 in 2024 to 39.4 in 2025. - The report’s geographic coverage includes Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report also includes market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, hotspot infographics, and updated graphics and tables. - Readers can access a free sample of the report. - Readers can also view the full market report.

Between the lines: - The forecast reflects a shift from treating age-related decline to trying to measure and manage aging earlier and more precisely. - The emphasis on AI, wearables and telehealth suggests longevity services are becoming more data-driven and less dependent on one-time clinic visits. - The strongest demand appears likely to come from consumers willing to pay for premium, personalized care rather than from traditional mass-market healthcare channels.

What's next: - The report expects clinics to expand use of predictive analytics, remote monitoring and regenerative therapies over the next several years. - Asia-Pacific’s faster growth could reshape where new clinics, wellness services and investment capital concentrate. - Premium anti-aging offerings are likely to keep expanding as high-net-worth consumer demand rises.

The bottom line: - Longevity clinics are becoming a high-growth global market, with the biggest gains likely to come from personalized, tech-enabled and premium care models.